CVE:NXG

NexgenRx - NXG Stock Forecast, Price & News

C$0.26

-0.03 (-8.62%)

(As of 09/27/2022 05:12 PM ET)

Add

Compare

Today's Range: C$0.27
▼
C$0.28
50-Day Range: C$0.27
▼
C$0.38
52-Week Range: C$0.27
▼
C$0.46

Volume: 28,300 shs
Average Volume: 40,009 shs
Market Capitalization: C$18.64 million

P/E Ratio: 5.30
Dividend Yield: 6.90%
Price Target: N/A

About NexgenRx

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Receive NXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter.

NXG Stock News Headlines

September 26, 2022 | finance.yahoo.com

Declining Stock and Solid Fundamentals: Is The Market Wrong About NexgenRx Inc. (CVE:NXG)?

September 23, 2022 | finance.yahoo.com

Nexgenrx Announces Declaration Of Dividend

September 12, 2022 | reuters.com

NXG.V - NexgenRx Inc. | Stock Price & Latest News | Reuters

October 19, 2021 | finance.yahoo.com

Is NexgenRx Inc.'s (CVE:NXG) Latest Stock Performance Being Led By Its Strong Fundamentals?

August 20, 2021 | finance.yahoo.com

I Ran A Stock Scan For Earnings Growth And NexgenRx (CVE:NXG) Passed With Ease

August 18, 2021 | finanznachrichten.de

NexgenRx Inc.: NexgenRx Announces Financial Results for Q2 2021 With Continued Growth in Revenues and Adjusted EBITDA

May 27, 2021 | finanznachrichten.de

NexgenRx Inc.: NexgenRx Announces Financial Results for Q1 2021 with Continued EBITDA and Net Profit Growth

March 31, 2021 | finance.yahoo.com

NexgenRx Announces 2020 Year End Results with Record EBITDA and Net Profit

February 2, 2021 | reuters.com

NXG.V - NexgenRx Inc. Profile | Reuters

August 25, 2020 | finance.yahoo.com

How Is NexgenRx's (CVE:NXG) CEO Paid Relative To Peers?

August 20, 2020 | finanznachrichten.de

NexgenRx Inc.: NexgenRx Announces 2020 Q2 Interim Results

August 20, 2020 | benzinga.com

NexgenRx Announces 2020 Q2 Interim Results

June 21, 2020 | www.barrons.com

NexgenRX Inc.

May 11, 2020 | www.baystreet.ca

NexgenRx Announces 2020 Q1 Interim Results

May 11, 2020 | www.finanznachrichten.de

NexgenRx Inc.: NexgenRx Announces 2020 Q1 Interim Results

February 5, 2020 | ca.finance.yahoo.com

Here's What We Think About NexgenRx Inc.'s (CVE:NXG) CEO Pay

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter.

NXG Company Calendar

Today: 9/28/2022
Next Earnings (Estimated): 11/17/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Health Care Plans
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:NXG
CUSIP: N/A
CIK: N/A
Web: www.nexgenrx.com
Phone: +1-416-6953393
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 5.30
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 6.57
Current Ratio: 1.09
Quick Ratio: 0.11

Sales & Book Value

Annual Sales: C$12.56 million
Price / Sales: 1.48
Cash Flow: C$0.02 per share
Price / Cash Flow: 11.60
Book Value: C$0.12 per share
Price / Book: 2.30

Miscellaneous

Outstanding Shares: 70,336,000
Free Float: N/A
Market Cap: C$18.64 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Ronald C. Loucks B.B.A. (Age 72)
Founder, CEO, Pres & Director
Comp: $230k

Mr. Kelly Elher C.A.
CPA, CA, CPA, Chief Financial Officer

Mr. Andrew Munroe
Sr. VP of Pharma & Payor Partners

Mr. Jason Robinson
Sr. VP of Admin.

Ms. Doreen Harvey
Lead HR

Mr. Paul Anthony Bolger LL.B.
M.B.A., Company Sec.

Mr. Avik Debroy
Financial Controller

Key Competitors

View All Competitors

Insiders & Institutions

Kelly Tyler Ehler
Bought 8,500 shares on 4/12/2022
Total: C$2,805.00 ($0.33/share)

View All Insider Transactions
View All Institutional Transactions

NXG Stock - Frequently Asked Questions

How have NXG shares performed in 2022?: NexgenRx's stock was trading at C$0.40 on January 1st, 2022. Since then, NXG stock has decreased by 33.8% and is now trading at C$0.27.
View the best growth stocks for 2022 here.
When is NexgenRx's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 17th 2022.
View our NXG earnings forecast.
Is NexgenRx a good dividend stock?: NexgenRx (CVE:NXG) pays an annual dividend of C$0.01 per share and currently has a dividend yield of 6.90%. NXG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 10.00%. This payout ratio is at a healthy, sustainable level, below 75%.
What other stocks do shareholders of NexgenRx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx investors own include WestJet Airlines (WJA) and Hydro One (H).

What is NexgenRx's stock symbol?: NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."
How do I buy shares of NexgenRx?: Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is NexgenRx's stock price today?: One share of NXG stock can currently be purchased for approximately C$0.27.
How much money does NexgenRx make?: NexgenRx (CVE:NXG) has a market capitalization of C$18.64 million and generates C$12.56 million in revenue each year.
How can I contact NexgenRx?: NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The official website for the company is www.nexgenrx.com. The company can be reached via phone at +1-416-6953393.

This page (CVE:NXG) was last updated on 9/28/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms